News Conference News ACC 2016 Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI Yael L. Maxwell April 04, 2016
News Conference News ACC 2016 ‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study Michael O'Riordan April 04, 2016
News Conference News ACC 2016 Watchman Left Atrial Appendage Closure Device Fares Well in Early Commercial Experience Todd Neale April 03, 2016
News Conference News ACC 2016 TAVR Mortality Declines as Volumes Increase: So How Many US Centers Are Enough? Shelley Wood April 03, 2016
News Conference News ACC 2016 Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH Michael O'Riordan April 03, 2016
News Conference News ACC 2016 TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral Shelley Wood April 02, 2016
News Features Where Theory Meets Practice: Getting to the Heart of the Heart Team Yael L. Maxwell March 30, 2016
News Daily News Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses Michael O'Riordan March 30, 2016
News Opinion Fellow Talk Balancing the Bias: On Learning to Interact With Industry Reps as a Fellow Luke Kohan, MD March 29, 2016
News Daily News Crushed Prasugrel Pills Beat Whole Tablets for Controlling Platelets During Primary PCI Caitlin E. Cox March 28, 2016
News Opinion Editor's Corner ACC 2016: HOPE for Primary Prevention, TAVR in Moderate-Risk Patients, Deferred Stenting in STEMI, and More Shelley Wood March 28, 2016
News Daily News Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs Michael O'Riordan March 25, 2016
News Daily News IVUS Guidance Beneficial for Diffuse Lesions in the Modern Stent Era Todd Neale March 22, 2016
News Features Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016 Caitlin E. Cox March 21, 2016
News Daily News Scoring System Simplifies Risk Assessment for Sudden Cardiac Death After NSTE ACS L.A. McKeown March 18, 2016
News Daily News FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent Michael O'Riordan March 16, 2016
News Daily News Calculator Estimates Spontaneous MI Risk in Medically Managed NSTE ACS Patients Todd Neale March 16, 2016
News Daily News Better Results With Newer Generation DES in Complex CAD Pave the Way for CABG Comparisons Todd Neale March 15, 2016
News Daily News FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting Michael O'Riordan March 14, 2016